Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeted IL-12 treatments and methods to stimulate haNK and NK92mi cells

Targeted IL-12 treatments and methods to stimulate haNK and NK92mi cells

US Patent 12098177 · Granted Sep 24, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Conditional modulation of therapy using recombinant cells2025
Conditional modulation of therapy using recombinant cells2025
Live cell imaging systems and methods to validate triggering of immune response2025
Neoepitope vaccine delivery vehicle and methods of making the same2025
Method of characterizing a tumor based on an immune gene expression signature in2025
Mesenchymal stem cell derived exosomes and methods2025
RP182 compositions and methods2025
Cellular adjuvants for viral infection2025
Cellular adjuvants for viral infection2025
Targeted neoepitope vectors and methods therefor2025
HIV treatment compositions and methods2025
Prediction of computational pathway circuits2025